DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
Rugo H, Barry WT, Moreno-Aspitia A. et al.
Abstract GS3-06: Long-term follow-up of CALGB 40502/NCCTG N063H (Alliance): A randomized phase III trial of weekly paclitaxel (P) compared to weekly nanoparticle albumin bound nab-Paclitaxel (NP) or ixabepilone (Ix) +/− bevacizumab as first-line therapy for locally recurrent or metastatic breast cancer (MBC).
Cancer Res 2018;
78 (4 Suppl.): GS3-06
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.